Authors: ENGERT A DIEHL V SCHNELL R RADSZUHN A HATWIG MT DRILLICH S SCHON G BOHLEN H TESCH H HANSMANN ML BARTH S SCHINDLER J GHETIE V UHR J VITETTA E

Citation: A. Engert et al., A PHASE-I STUDY OF AN ANTI-CD25 RICIN A-CHAIN IMMUNOTOXIN (RFT5-SMPT-DGA) IN PATIENTS WITH REFRACTORY HODGKINS LYMPHOMA, Blood, 89(2), 1997, pp. 403-410

Authors: SCHNELL R HATWIG MT RADSZUHN A CEBE F DRILLICH S SCHON G BOHLEN H HANSMANN ML SCHINDLER J GHETIE V UHR J DIEHL V VITETTA ES ENGERT A

Citation: R. Schnell et al., A CLINICAL-PHASE-I STUDY OF AN ANTI-CD25-DEGLYCOSYLATED RICIN A-CHAINIMMUNOTOXIN (RFT5-SMPT-DGA) IN PATIENTS WITH REFRACTORY HODGKINS-DISEASE, European journal of cancer, 31A, 1995, pp. 930-930

Authors: SCHNELL R HATWIG MT RADSZUHN A CEBE F DRILLICH S SCHON G BOHLEN H TESCH H HANSMANN ML SCHINDLER J GHETIE Y UHR J DIEHL Y VITETTA ES ENGERT A

Citation: R. Schnell et al., A CLINICAL-PHASE-I TRIAL OF AN ANTI-CD25-DEGLYCOSYLATED RICIN A-CHAINIMMUNOTOXIN IN PATIENTS WITH REFRACTORY HODGKINS-DISEASE, Blood, 86(10), 1995, pp. 208-208